Skip to content
DataLookout
Menu

POLYVIHNCT07388394

Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 3 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment resumed after suspension Show 4 more changesShow less
    • Eligibility criteria expanded, about 7 words
    • Primary and study completion pushed from May 31, 2027 to Aug 31, 2027
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised
  2. Stopped Recruitment suspended Sponsor's reason: The inclusions have been suspended pending approval of an amendment to the protocol
    • Site details revised
    v3
  3. Notable Recruitment opened
    • Start date changed from estimate of Feb 15, 2026 to Jan 28, 2026
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Describe polypharmacy among people living with HIV aged 75 and older.
Timeframe: 18 months

Secondary (3)

Assess the most common comorbidities associated with polypharmacy in the population of PLHIV aged 75
Assess whether people taking multiple medications have a lower treatment adherence score than those taking fewer medications.
Assess the level of functional independence in this age group and link it to the existence of polypharmacy.

Arms and interventions

people living with HIV over the age of 75Other

Other: interview with advanced practice nurse

Sites

1 site in 1 country

  • CHU de NICENice, CHU de Nice, France